Skip navigation

Explore the Future of Clinical Trials | A Look at Innovative mHealth and Real-world Evidence Initiatives

February 15-16, 2017
  • PA, NJ
CHOOSE THE DATE AND LOCATION BEST FOR YOU!

February 15, 2017 | King of Prussia, PA
Ruth’s Chris Steak House

February 16, 2017 | Mendham, NJ
Black Horse Tavern

Attendance is by Invitation Only and is Complimentary. Limited to representatives from drug and medical device manufacturers and contract research organizations.

Incorporating Data from Real-World Evidence and mHealth in Clinical Trials — Where Do We Stand Today?

Today, data derived from real-world evidence (RWE) is becoming a key component in the life sciences product lifecycle, not only for biopharmaceutical companies, but also for payer institutions. Real-world evidence enables both drug manufacturers and payers to understand how drug products are working for patients in actual settings. Recently, payers have been demanding that drug manufacturers provide data based on real-world evidence to back up their product value claims and differentiate one drug from another.

CBI’s Clinical Innovation Seminar brings together key industry researchers and thought leaders in an invitation-only, small-group setting for a pragmatic review and discussion of the state of the industry around RWE and mHealth.

Attendees will participate in an interactive dialogue based on leading research and initiatives, including:

  • Tufts CSDD — A Study Among Key Stakeholders on the Use of Real World Data and Evidence in Clinical Research
  • Tufts CSDD — Evaluate the Value and Return of mHealth Technologies
  • Independent industry survey regarding the current state of mHealth in clinical trials

FOR MORE INFORMATION, PLEASE CONTACT:
JOHN FOSDICK | [email protected] | 339-298-2142

CBI’s Clinical Innovation Seminar

Explore the Future of Clinical Trials | A Look at Innovative mHealth and Real-world Evidence Initiatives

CHOOSE THE DATE AND LOCATION BEST FOR YOU!

February 15, 2017 | King of Prussia, PA
Ruth’s Chris Steak House

February 16, 2017 | Mendham, NJ
Black Horse Tavern

Attendance is by Invitation Only and is Complimentary. Limited to representatives from drug and medical device manufacturers and contract research organizations.

Incorporating Data from Real-World Evidence and mHealth in Clinical Trials — Where Do We Stand Today?

Today, data derived from real-world evidence (RWE) is becoming a key component in the life sciences product lifecycle, not only for biopharmaceutical companies, but also for payer institutions. Real-world evidence enables both drug manufacturers and payers to understand how drug products are working for patients in actual settings. Recently, payers have been demanding that drug manufacturers provide data based on real-world evidence to back up their product value claims and differentiate one drug from another.

CBI’s Clinical Innovation Seminar brings together key industry researchers and thought leaders in an invitation-only, small-group setting for a pragmatic review and discussion of the state of the industry around RWE and mHealth.

Attendees will participate in an interactive dialogue based on leading research and initiatives, including:

  • Tufts CSDD — A Study Among Key Stakeholders on the Use of Real World Data and Evidence in Clinical Research
  • Tufts CSDD — Evaluate the Value and Return of mHealth Technologies
  • Independent industry survey regarding the current state of mHealth in clinical trials

FOR MORE INFORMATION, PLEASE CONTACT:
JOHN FOSDICK | [email protected] | 339-298-2142